Durga Kanigicherla
Overview
Explore the profile of Durga Kanigicherla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wong K, Pitcher D, Braddon F, Downward L, Steenkamp R, Masoud S, et al.
Kidney Int Rep
. 2024 Jul;
9(7):2067-2083.
PMID: 39081723
Introduction: The National Registry of Rare Kidney Diseases (RaDaR) collects data from people living with rare kidney diseases across the UK, and is the world's largest, rare kidney disease registry....
2.
Storrar J, McDonnell T, Ragy O, Kanigicherla D, Sinha S
Clin Kidney J
. 2024 Apr;
17(4):sfae066.
PMID: 38577270
No abstract available.
3.
Wong K, Pitcher D, Braddon F, Downward L, Steenkamp R, Annear N, et al.
Lancet
. 2024 Mar;
403(10433):1279-1289.
PMID: 38492578
Background: Individuals with rare kidney diseases account for 5-10% of people with chronic kidney disease, but constitute more than 25% of patients receiving kidney replacement therapy. The National Registry of...
4.
McDonnell T, Hartemink J, Ragy O, Parker K, Shukkur M, Thachil J, et al.
Glomerular Dis
. 2023 Dec;
3(1):266-274.
PMID: 38054033
Introduction: Thromboembolic events (TEEs) are a serious and potentially fatal complication of nephrotic syndrome (NS). Despite this, there is a lack of evidence examining the benefits of prophylactic anticoagulation (PAC)...
5.
Parker K, Ragy O, Hamilton P, Thachil J, Kanigicherla D
Res Pract Thromb Haemost
. 2023 Sep;
7(6):102162.
PMID: 37680313
Thromboembolism is one of the most serious complications of nephrotic syndrome, including both arterial and venous thromboembolic events. Rates of thromboembolism depend on a multitude of factors, including the severity...
6.
Hamilton P, Blaikie K, Roberts S, Gittins M, Downie M, Gupta S, et al.
PLoS One
. 2023 Apr;
18(4):e0281795.
PMID: 37104302
Background: Despite MN being one of the most common causes of nephrotic syndrome worldwide, its biological and environmental determinants are poorly understood in large-part due to it being a rare...
7.
Ragy O, Rautemaa V, Smith A, Brenchley P, Kanigicherla D, Hamilton P
PLoS One
. 2023 Feb;
18(2):e0281726.
PMID: 36827283
Background: Since the emergence of the anti-PLA2R antibody (PLA2R-Ab) test, nephrology practice has not changed dramatically, with most nephrologists still relying on a kidney biopsy to diagnose membranous nephropathy. In...
8.
Hamilton P, Kanigicherla D, Hanumapura P, Blaikie K, Ritchie J, Sinha S, et al.
J Clin Apher
. 2021 Nov;
37(1):40-53.
PMID: 34753218
Membranous nephropathy associated with anti-PLA R autoantibody is a significant cause of nephrotic syndrome worldwide. Treatment remains empiric with a significant side-effect burden despite an increase in our understanding of...
9.
Hamilton P, Wilson F, Chinnadurai R, Sinha S, Singh M, Ponnusamy A, et al.
Clin Kidney J
. 2020 Feb;
13(1):27-34.
PMID: 32082550
Background: Membranous nephropathy (MN) represents two distinct disease entities. Primary MN is now recognized as an autoimmune condition associated with the anti-PLAR antibody and secondary MN occurs in tandem with...
10.
Hamilton P, Kanigicherla D, Venning M, Brenchley P, Meads D
Nephrol Dial Transplant
. 2018 Apr;
33(12):2145-2155.
PMID: 29617884
Background: Membranous nephropathy is among the most common causes of nephrotic syndrome worldwide, with a high healthcare burden. Treatment using the modified Ponticelli regimen (mPR) has remained the standard of...